|
Sign In to gain access to subscriptions and/or personal tools.
|
Pre-treatment with candesartan protects from cerebral ischaemia
Takeshi Ito
Section on Pharmacology, NIMH, NIH, Bethesda MD 20892, USA
Yasuaki Nishimura
Section on Pharmacology, NIMH, NIH, Bethesda MD 20892, USA
Juan Saavedra
Section on Pharmacology, NIMH, NIH, Bethesda MD 20892, USA, Saavedrj{at}irp.nimh.nih.gov
Angiotensin II (Ang II) regulates cerebral blood flow by stimulating cerebral vasoconstriction via AT1receptors. In adult spontaneously hypertensive rats (SHR), the cerebrovascular autoregulatory curve is shifted to the right, in the direction of higher blood pressures, an indication of excessive cerebrovascular vasoconstriction. A restricted capacity to dilate cerebral blood vessels may be responsible for the enhanced vulnerability to cerebrovascular ischaemia during hypertension. We found that chronic treatment with the AT1-receptor antagonist, candesartan, (0.5 mg/kg/day for 14 days, via osmotic minipumps implanted in the subcutaneous tissue) blocked Ang II binding to AT1 -receptors in cerebral blood vessels and in brain areas involved in the regulation of cerebrovascular flow, and increased the ratio of lumen-wall area in the middle cerebral artery. Candesartan treatment normalised the lower part of the autoregulatory curve in SHR, and markedly decreased cerebral ischaemia as a consequence of middle cerebral artery occlusion with reperfusion. Protection from ischaemia is related to arterial remodelling, enhanced compensatory vasodilatation in the peripheral area of ischaemia, decreased reduction in cerebral blood flow following the occlusion of a major cerebral blood vessel, and protection from injury in the periphery of the lesion. Our results indicate that pre-treatment with AT1-antagonists such as candesartan could be of benefit in the prevention and treatment of brain ischaemia.
Key Words: renin angiotensin system angiotensin receptors genetic hypertension stroke brain injury
References
- Saavedra JM Emerging features of brain Angiotensin receptors. Regul Pept 1999;85:31-45.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Speth RC, Harik SI Angiotensin II receptor binding sites in brain microvessels. Proc Natl Acad Sci USA 1985;82:6340-3.[Abstract/Free Full Text]
- Brecher P., Tercyak A., Chobanian AV Properties of angiotensin-converting enzyme in intact cerebral micro vessels. Hypertension 1981;3:198-204.[Abstract/Free Full Text]
- Tsutsumi K., Saavedra JM Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol 1991;261:H667-H670.[Web of Science][Medline]
[Order article via Infotrieve]
- Squire IB Actions of angiotensin II on cerebral blood flow autoregulation in health and disease. J Hypertens 1994;12: 1203-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Postiglione A., Bobkiewicz T., Vinholdtpedersen E., Lassen NA, Paulson OB, Barry DI Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats. Stroke 1991;22:1362-8.[Web of Science]
- Paulson OB,Waldemar G. Role of the local renin-angiotensin system in the autoregulation of the cerebral circulation. Blood Vessels 1991;28:231-5.[Web of Science][Medline]
[Order article via Infotrieve]
- Torup M., Waldemar G., Paulson OB Ceranapril and cerebral blood flow autoregulation. J Hypertens 1993;1:399-405.
- Hajdu MA, Heistad DD, Ghoneim S., Baumbach GF Effects of antihypertensive treatment on composition of cerebral arterioles. Hypertension 1991;18(Suppl. II):1115-21.
- Fujii K.,Weno BL, Baumbach GL, Heistad DD Effect of antihypertensive treatment on focal cerebral infarction. Hypertension 1992;19:713-6.[Abstract/Free Full Text]
- Vraamak T., Waldemar G., Strandgaard S., Paulson S. Angiotensin II receptor antagonist Candesartan and cerebral blood flow autoregulation. J Hypertens 1995;13:755-61.[Web of Science][Medline]
[Order article via Infotrieve]
- Nishimura Y., Xu T., Jöhren O., Häuser W., Saavedra JM The angiotensin AT1 receptor antagonist Candesartan regulates cerebral blood flow and brain angiotensin AT1 receptor expression. Basic Res Cardiol 1998;93(suppl 2):63-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tsutsumi K., Saavedra JM Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 1991;261:R209-R216.[Web of Science][Medline]
[Order article via Infotrieve]
- Nazarali AJ, Gutkind JS, Saavedra JM Calibration of [125I]-polymer standards with [125I]-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Meth 1989;30:247-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Paxinos G., Watson Ch. The rat brain in stereotaxic coordinates. Academic Press, New York, 1986, 1-118.
- Nag S., Kilty DW Cerebrovascular changes in chronic hypertension. Stroke 1997;28:1028-34.[Abstract/Free Full Text]
- Dirnagl U., Kaplan B., Jacewicz M., Pulsinelli W. Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model.J Cereb Blood Flow Metab 1989; 9:589-96.[Web of Science][Medline]
[Order article via Infotrieve]
- Zea Longa E.,Weinstein PR, Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.[Abstract/Free Full Text]
- Bederson JB,Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986; 17:1304-8.[Abstract/Free Full Text]
- Swanson RA, Morton MT, Tsao-Wu G., Savalos RA, Davidson C., Sharp RF A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-5.[Web of Science][Medline]
[Order article via Infotrieve]
- Nishimura Y., Ito T., Saavedra JM Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000; 31:2478-86.[Abstract/Free Full Text]
- Veniant M., Clozel JP, Kuhn P., Clozel M. Protective effect of cilazapril on the cerebral circulation. J Cardiovasc Pharmacol 1992;19(suppl.6):S94-S99.[Web of Science][Medline]
[Order article via Infotrieve]
- Saavedra JM, Nishimura Y. Angiotensin and cerebral blood flow. Cell Mol Neurobiol 1999;19:553-73.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Saavedra JM Brain and pituitary angiotensin. Endocr Rev 1992;13:329-80.[Abstract/Free Full Text]
- Nishimura Y., Ito T., Hoe K.-L, Saavedra JM Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors. Brain Res 2000;871:29-38.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sever PS Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists. J Hum Hypertens 1999;13(suppl.1): 503-10.
- Werner C., Hoffman WE, Kochs E., Rabito SF, Miletich DJ Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke 1991;22:910-4.[Abstract/Free Full Text]
- Dai W.-J, Funk A., Herdegen T., Unger T., Culman J. Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 1999;30:2391-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Blezer ELA, Klaas N., Bar D. et al. Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats. Stroke 1998;29:1671-8.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 3,
174-179 (2001)
DOI: 10.3317/jraas.2001.024

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. C. Newman, H. Bang, S. I. Hussain, and J. F. Toole
Association of diabetes, homocysteine, and HDL with cognition and disability after stroke
Neurology,
November 27, 2007;
69(22):
2054 - 2062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhou, J. Pavel, M. Macova, Z.-X. Yu, H. Imboden, L. Ge, T. Nishioku, J. Dou, E. Delgiacco, and J. M. Saavedra
AT1 Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive Rats
Stroke,
May 1, 2006;
37(5):
1271 - 1276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Forder, D. H. Munzenmaier, and A. S. Greene
Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat
Am J Physiol Heart Circ Physiol,
April 1, 2005;
288(4):
H1989 - H1996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ando, J. Zhou, M. Macova, H. Imboden, and J. M. Saavedra
Angiotensin II AT1 Receptor Blockade Reverses Pathological Hypertrophy and Inflammation in Brain Microvessels of Spontaneously Hypertensive Rats
Stroke,
July 1, 2004;
35(7):
1726 - 1731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kusaka, G. Kusaka, C. Zhou, M. Ishikawa, A. Nanda, D. N. Granger, J. H. Zhang, and J. Tang
Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury
Am J Physiol Heart Circ Physiol,
June 1, 2004;
286(6):
H2442 - H2451.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|